Biosimilars and Inpatient - Pharmacist Digest

CMS Issues Sweeping End-Of Year Rule on Medicare Advantage and Medicare Part D

Putting Patients First Blog

DECEMBER 9, 2024

CMS is proposing setting a 20% coinsurance/equivalent copayment limit for behavioral health services, eliminating cost-sharing for opioid treatment program services, and capping inpatient psychiatric service cost sharing to 100% of Medicare Fee-For-Services levels.

Medication Therapy Management (MTM)

Medication Therapy Management (MTM) Biosimilars Inpatient Communication

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Pharmacy Times

JUNE 16, 2025

Literature suggests a 3% difference in the rate of FN between CSF agents filgrastim (Neupogen; Amgen)/filgrastim biosimilars and pegfilgrastim (Neulasta; Amgen)/pegfilgrastim biosimilars. A retrospective chart review was performed. Forty-four of 88 charts met the inclusion criteria and were evaluated using the Fisher exact test.

Inpatient

Inpatient HIV Treatment and Prevention Agents Pharmacy Technician Chemotherapy

UK scientists trial Humira biosimilar for COVID-19 in care homes

pharmaphorum

OCTOBER 1, 2020

Adalimumab – sold by AbbVie as Humira as well as in biosimilar form by companies including Novartis’ Sandoz unit, Amgen and Biogen/Samsung joint venture Bioepis – will be used in the phase 2 AVID-CC study to see if it can prevent progression to respiratory failure in people with coronavirus infections.

Biosimilars

Biosimilars Hospitals Inpatient

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

Pharmacy Times

JUNE 17, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Pharmacy Management Diabetes

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

JUNE 10, 2025

Related Videos Related Content Advertisement June 10th 2025 Inpatient Biosimilar Use Grows, Offering Cost-Saving Opportunities for Health Systems Aislinn Antrim, Managing Editor June 3rd 2025 S2. December 21, 2004. Subscribe Now!

Pharmacy Technician

Pharmacy Technician HIV Treatment and Prevention Agents Compounding Pharmacies Biosimilars

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Pharmacy Times

JUNE 11, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Biosimilars Pharmacy Management

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Pharmacy Times

JUNE 11, 2025

Related Videos Related Content Advertisement June 11th 2025 Perioperative Nivolumab Shows Long-Term EFS, Favorable OS in Resectable NSCLC Luke Halpern, Assistant Editor June 3rd 2025 S2.

Pharmacy Technician

Pharmacy Technician Specialty Pharmacies Biosimilars Compounding Pharmacies

FDA Would Like to Join You in the Sandbox When Developing AI Enabled Devices

FDA Law Blog: Biosimilars

MARCH 6, 2025

inpatient hospital, out-patient clinic), date range for the data, and location of the data collection sites (e.g., OUS data may introduce bias if the OUS population does not reflect the U.S. population due to differences in demographics, practice of medicine, or standard of care. The DCP may also define the sources of the data (e.g.,

Documentation

Documentation Inpatient Labelling Hospitals

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Pharmacy Times

JUNE 11, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician

Pharmacy Technician Biosimilars Compounding Pharmacies Pharmacy Management

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Pharmacy Times

JUNE 17, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Mail-Order Pharmacies

Mail-Order Pharmacies Pharmacy Technician Compounding Pharmacies Inpatient

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Pharmacy Times

JUNE 17, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Dosage

Dosage Pharmacy Technician Compounding Pharmacies Inpatient

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

Pharmacy Times

JUNE 16, 2025

Related Videos Related Content Advertisement June 16th 2025 Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor Adam Musante, PharmD Marissa Aquino, PharmD Meredith Vigneaux, PharmD June 3rd 2025 S2. HOPA has selected 4.0 Additional information is available here.

Pharmacy Technician

Pharmacy Technician Specialty Pharmacies Compounding Pharmacies Inpatient

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Pharmacy Times

JUNE 20, 2025

For effective patient care, we need smart people to design workflows for operationalizing 505(b)(2) drugs, integrating the next biosimilar we have to stock, and managing the compounding of a new hazardous drug. We need people to coordinate and track prior authorizations, write persuasive appeal letters, and keep patients updated.

Pharmacy Technician

Pharmacy Technician Compounding Compounding Pharmacies Biosimilars

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

Pharmacy Times

JUNE 17, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Diabetes

Diabetes Pharmacy Technician Compounding Pharmacies Hospitals

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Pharmacy Times

JUNE 19, 2025

Trends Pharmacol Sci. 2024;45(5):406-418. doi:10.1016/j.tips.2024.03.004

Pharmacy Technician

Pharmacy Technician Diabetes Compounding Compounding Pharmacies

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Pharmacy Times

JUNE 13, 2025

Traditionally administered in inpatient or observation settings due to concerns of cytokine release syndrome (CRS) and other acute toxicities, step-up dosing (SUD) regimens have emerged as a strategy to mitigate these risks.

Pharmacy Technician

Pharmacy Technician Hospitals Compounding Pharmacies Immunity

Does the Drug Shortage White Paper Fall Short?

FDA Law Blog: Biosimilars

APRIL 8, 2024

To address the underlying causes of shortages, the White Paper suggests that the creation (by Congress) of two programs that link inpatient hospital purchasing and payment decisions to supply chain resilience practices would better incentivize investments in mature manufacturing practices.

Inpatient

Inpatient Hospitals Dosage Controlled Substances

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Pharmacy Times

JUNE 18, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Pharmacy Management

High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma

Pharmacy Times

JUNE 16, 2025

Related Videos Related Content Advertisement June 16th 2025 Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor Adam Musante, PharmD Marissa Aquino, PharmD Meredith Vigneaux, PharmD June 3rd 2025 S2. Subscribe Now!

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Immunity Immunization

CMS Final Medicaid Drug Rebate Rule Details New Misclassification Penalties and Numerous Other Changes

FDA Law Blog: Biosimilars

SEPTEMBER 30, 2024

physicians services or inpatient hospitals services) and for which Medicaid payment may be made as part of payment for the service “and not as direct reimbursement for the drug.” 1396r-8(k)(3).

Vaccines

Vaccines Inpatient Packaging Documentation

Review Demonstrates Impaired Quality of Life in Children With Pneumococcal Disease Despite Variations in Study Methodologies

Pharmacy Times

JUNE 18, 2025

for inpatient pneumonia, and 0.412 to 0.82 Utility estimates from original CUA studies sourced during the analysis demonstrated considerable variability, with ranges of −0.330 to 0.6882 for meningitis, −0.331 to 0.93 for nonmeningitis invasive pneumococcal disease, −0.054 to 0.71 for outpatient pneumonia, the investigators found.

Pharmacy Technician

Pharmacy Technician Vaccines Immunity Immunization

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

Pharmacy Times

JUNE 18, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Pharmacy Management

. - Drug registration number Medicines (Advertisement & Sale) Act 1956 and Regulations - To learn prohibitions of medicine advertisement and Medicine Advertisement Board Registration of Pharmacists Act 1951 and Regulations - Pharmacy Board Malaysia and legislation aspects of provisional, full and temporary registration Code of Ethics for Pharmacists (..)

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy

Do We Really Pay More for Prescription Drugs in the United States?

Pharmacy Times

JUNE 12, 2025

5 The Most Significant Driver of Health Care Spend Isn’t Drugs—It Isn’t Even Close Pharmaceutical manufacturers are a frequent punching bag for politicians, mostly because they are easy targets, and they tend to have more visible out-of-pocket exposure. Subscribe Now!

Pharmacy Technician

Pharmacy Technician Community Pharmacies Drug Pricing Hospitals

Pharmacist Digest

CMS Issues Sweeping End-Of Year Rule on Medicare Advantage and Medicare Part D

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Trending Sources

UK scientists trial Humira biosimilar for COVID-19 in care homes

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

FDA Would Like to Join You in the Sandbox When Developing AI Enabled Devices

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Does the Drug Shortage White Paper Fall Short?

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma

CMS Final Medicaid Drug Rebate Rule Details New Misclassification Penalties and Numerous Other Changes

Review Demonstrates Impaired Quality of Life in Children With Pneumococcal Disease Despite Variations in Study Methodologies

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

Contents

Do We Really Pay More for Prescription Drugs in the United States?

Stay Connected